Merck has shown consistent approach to their corporate social responsibility agenda in Africa and India since 2013

Merck has shown consistent approach to their corporate social responsibility agenda in Africa and India since 2013

The Merck Capacity Advancement Program was kicked off successfully in 7 sub- Saharan countries

NAIROBI, Kenya, October 21, 2014/ -- The Merck Capacity Advancement Program (http://www.merckgroup.com) aims at expanding the professional capacity in the areas of research and development, clinical research, supply chain integrity and efficiency, pharmacovigilance, community awareness and medical education for medical and pharmacy undergraduates, physicians and pharmacists in rural areas.

Logo: http://www.photos.apo-opa.com/plog-content/images/apo/logos/merck_logo.jpg

Photo 1: http://www.photos.apo-opa.com/index.php?level=picture&id=1456 (Rasha kelej , Vice president and head of Global Business Responsibility and Market Development at Merck Diabetes awarenes campaign in Luwerro)

Photo 2: http://www.photos.apo-opa.com/index.php?level=picture&id=1455 (Dr Frank Stangenberg Haverkamp receiving a trophy of appreciation by Kenya Minister of Health at Serena hotel)

The 5 year program was kicked off successfully in 7 sub- Saharan countries which are Kenya, Uganda, Namibia Angola, Ghana, Tanzania and Mozambique and will further expand to other Sub-Saharan and Asian countries in 2014.

 

Download the documentation: www.apo-mail.org/Merck-CAP-From-Africa-To-India.doc

 

Distributed by APO (African Press Organization) on behalf of Merck KGaA.

 

Media contact:

Elizabeth Njeri

[email protected]

SOURCE

Merck KGaA

Suggested Articles

Amgen could soon face new competition in the PCSK9 class, but an efficacy boost in treating high-risk heart attack patients could help keep it ahead.

Having already whiffed on one crucial heart failure trial, Novartis is focusing on "profound" data from its Entresto studies in hopes for another go.

Bristol-Myers Squibb and Pfizer's Eliqus has taken the U.S. warfarin alternative market by storm, but can AFib screening amp it up even more?